What is the appropriate dosage and usage of Bactrim (trimethoprim-sulfamethoxazole) for a 9-year-old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The appropriate dosage of Bactrim (trimethoprim-sulfamethoxazole) for a 9-year-old patient is typically 8-12 mg/kg/day of the trimethoprim component, divided into two doses, as recommended by the most recent and highest quality study 1.

Dosage Calculation

To calculate the dosage, the trimethoprim component is used, with a typical dose range of 8-12 mg/kg/day. For a 9-year-old patient, this would translate to:

  • 8 mg/kg/day of trimethoprim, which is equivalent to 40 mg/kg/day of sulfamethoxazole, divided every 12 hours for 10-14 days for a standard urinary tract infection.

Important Considerations

  • The medication should be given with plenty of fluids to prevent crystalluria.
  • Dosing should be adjusted if the child has kidney impairment.
  • Common side effects include rash, gastrointestinal upset, and photosensitivity, so sun protection is advised.
  • Parents should be instructed to complete the full course of antibiotics even if symptoms improve.

Mechanism of Action

This medication works by inhibiting two steps in bacterial folate synthesis, creating a synergistic antibacterial effect that is effective against many common pathogens.

Monitoring for Adverse Effects

If the child develops severe rash, difficulty breathing, or persistent fever while taking Bactrim, medical attention should be sought immediately, as indicated in various studies, including 1 and 1.

From the FDA Drug Label

Pediatric Use: Sulfamethoxazole and trimethoprim is not recommended for infants younger than 2 months of age (see INDICATIONS and CONTRAINDICATIONS sections).

The FDA drug label does not provide specific dosage and usage guidelines for a 9-year-old patient taking Bactrim (trimethoprim-sulfamethoxazole).

From the Research

Dosage and Usage of Bactrim for a 9-year-old Patient

  • The appropriate dosage and usage of Bactrim (trimethoprim-sulfamethoxazole) for a 9-year-old patient are not explicitly stated in the provided studies.
  • However, according to 2, Bactrim is used as an alternative to ampicillin and amoxicillin in children with otitis media, and is preferred when these patients are penicillin-sensitive or when the infection is caused by beta-lactamase-producing Haemophilus influenzae.
  • A study published in 3 compared the effectiveness of twice-daily trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate in the treatment of acute otitis media in children, and found that trimethoprim-sulfamethoxazole was more effective clinically and produced fewer side effects.
  • The dosage of trimethoprim-sulfamethoxazole should be adjusted when the creatinine clearance is less than 30 ml/min, as stated in 4.
  • Bactrim is active in vitro against various gram-positive and gram-negative bacteria, and is useful for prophylaxis and treatment of selected infections of the genitourinary, respiratory, and gastrointestinal tracts, as mentioned in 4 and 5.

Potential Side Effects and Interactions

  • Common adverse reactions to trimethoprim-sulfamethoxazole include gastrointestinal intolerance and skin eruptions, as stated in 2.
  • Hematologic reactions, such as anemia, thrombocytopenia, granulocytopenia, and agranulocytosis, can occur rarely, as mentioned in 2.
  • The incidence of untoward reactions to trimethoprim-sulfamethoxazole compares favorably with that of standard agents administered for the same indications, as stated in 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug therapy reviews: trimethoprim-sulfamethoxazole.

American journal of hospital pharmacy, 1979

Research

Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1990

Research

Trimethoprim-sulfamethoxazole.

Mayo Clinic proceedings, 1991

Research

Trimethoprim-sulfamethoxazole and other sulfonamides.

The Medical clinics of North America, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.